NCT01126268View on ClinicalTrials.gov

Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
ImpetigoFolliculitisSecondarily Infected EczemaMinor Soft Tissue Infections
Interventions
DRUG

Retapamulin (Altabax)

Retapamulin ointment, applied topically twice daily for five days

Trial Locations (1)

77030

Houston Medical Center Building, Houston

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

The University of Texas Health Science Center, Houston

OTHER

NCT01126268 - Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection | Biotech Hunter | Biotech Hunter